CAL
BIO icon

Capital Advisors Ltd’s Bio-Rad Laboratories Class A BIO Stock Holding History

Capital Advisors Ltd’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10K Hold
35
– – ﹤0.01% 849
2026
Q1 		$10K Hold
35
– – ﹤0.01% 821
2025
Q4 		$11K Hold
35
– – ﹤0.01% 778
2025
Q3 		$10K Sell
35
-60
-63% -$16.3K ﹤0.01% 795
2025
Q2 		$23K Buy
95
+4
+4% +$946 ﹤0.01% 602
2025
Q1 		$22K Sell
91
-3
-3% -$902 ﹤0.01% 600
2024
Q4 		$31K Hold
94
– – ﹤0.01% 538
2024
Q3 		$31K Hold
94
– – ﹤0.01% 536
2024
Q2 		$26K Buy
94
+62
+194% +$18K ﹤0.01% 559
2024
Q1 		$11K Buy
32
+1
+3% +$329 ﹤0.01% 689
2023
Q4 		$10K Sell
31
-12
-28% -$3.76K ﹤0.01% 685
2023
Q3 		$15K Buy
43
+12
+39% +$4.63K ﹤0.01% 602
2023
Q2 		$12K Sell
31
-8
-21% -$3.26K ﹤0.01% 651
2023
Q1 		$19K Hold
39
– – ﹤0.01% 466
2022
Q4 		$16K Buy
39
+6
+18% +$2.42K ﹤0.01% 484
2022
Q3 		$14K Sell
33
-1
-3% -$499 ﹤0.01% 486
2022
Q2 		$17K Buy
34
+3
+10% +$1.56K ﹤0.01% 449
2022
Q1 		$17K Hold
31
– – ﹤0.01% 458
2021
Q4 		$23K Buy
+31
New +$23.2K ﹤0.01% 419

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Advisors Ltd's BIO Position: Q2 2026 in Review

Capital Advisors Ltd held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 35 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #849.

Capital Advisors Ltd first reported a position in BIO in Q4 2021 and has held it in 19 quarters since. The position peaked at $31K in Q4 2024. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Capital Advisors Ltd held 35 shares of Bio-Rad Laboratories Class A worth $10K as of Q2 2026.
  • Capital Advisors Ltd left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #849 holding.
  • Capital Advisors Ltd first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and has held it in 19 quarters since.
  • Capital Advisors Ltd's Bio-Rad Laboratories Class A position peaked at $31K in Q4 2024.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.